
Fauci “cautiously optimistic” about safe, effective COVID-19 vaccine in late fall, early winter
An experimental COVID-19 vaccine being developed by Fauci’s agency and biotechnology company Moderna, known as mRNA-1273, started phase 3 clinical trial
An experimental COVID-19 vaccine being developed by Fauci’s agency and biotechnology company Moderna, known as mRNA-1273, started phase 3 clinical trial
Fauci said the United States is currently averaging between 1.5 million and 2 million tests per week